Origination Date – 06/30/2017
Expiration Date – 06/30/2021
The goal of this course is to enhance the knowledge of physicians and other healthcare providers about marijuana perceptions and usage among perinatal populations. This module will also discuss the prevalence and long-term impacts marijuana usage may have on pregnant women and their children. By enhancing their knowledge, physicians and other healthcare providers can better assess patients who use marijuana and provide informed guidance to their patients regarding marijuana use.
- Recognize the basic pharmacology, pharmacokinetics, and methods of marijuana use
- Explain marijuana urine testing
- Describe the prevalence of marijuana use among perinatal populations
- Describe the long-term impacts marijuana may have on pregnant women and the neonate
- Identify strategies for communicating risk and providing guidance to pregnant patients
George Sam Wang, MD, FAAP
Assistant Professor of Pediatrics
Section of Emergency Medicine, Medical Toxicology
Department of Pediatrics
University of Colorado Anschutz Medical Campus, Children's Hospital Colorado
Dr. Wang, completed his pediatric residency and pediatric emergency medicine fellowship at Children's Hospital Colorado/Anschutz Medical Campus, and his medical toxicology fellowship at the Rocky Mountain Poison and Drug Center at Denver Health. He is an Assistant Professor of Pediatrics at Children's Hospital Colorado/Anschutz Medical Campus where he is a PEM and toxicology attending.
Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-95877701. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications.